1. Upper and lower respiratory disease. (©2003) Other Names: Corren, Jonathan; Togias, Alkis; Ph.D, Bousquet, Jean Record Type: Book Extent: 1 online resource (471 pages), illustrations View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Omalizumab in the treatment of asthma. (December 2011) Authors: Tan, Ricardo; Corren, Jonathan Journal: Expert review of respiratory medicine Issue: Volume 5:Number 6(2010) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Omalizumab in the treatment of asthma. (December 2011) Authors: Tan, Ricardo; Corren, Jonathan Journal: Expert review of respiratory medicine Issue: Volume 5:Number 6(2010) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Issue 1 (January 2022) Authors: Menzies-Gow, Andrew; Gurnell, Mark; Heaney, Liam G; Corren, Jonathan; Bel, Elisabeth H; Maspero, Jorge; Harrison, Timothy; Jackson, David J; Price, David; Lugogo, Njira; Kreindler, James; Burden, Annie; de Giorgio-Miller, Alex; Padilla, Kelly; Martin, Ubaldo J; Garcia Gil, Esther Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EAACI Biologicals Guidelines—Recommendations for severe asthma. Issue 1 (10th August 2020) Authors: Agache, Ioana; Akdis, Cezmi A.; Akdis, Mubeccel; Canonica, Giorgio Walter; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; Chu, Derek K.; Del Giacco, Stefano; Eiwegger, Thomas; Flood, Breda; Firinu, Davide; Gern, James E.; Hamelmann, Eckard; Hanania, Nicola; Hernández‐Martín, Irene; Knibb, Rebe... Journal: Allergy Issue: Volume 76:Issue 1(2021) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. Issue 9 (31st January 2022) Authors: Bachert, Claus; Corren, Jonathan; Lee, Stella E.; Zhang, Haixin; Harel, Sivan; Cunoosamy, Danen; Khan, Asif H.; Jacob‐Nara, Juby A.; Siddiqui, Shahid; Nash, Scott; Rowe, Paul J.; Deniz, Yamo Journal: International forum of allergy & rhinology Issue: Volume 12:Issue 9(2022) Page Start: 1191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Issue 6 (9th February 2022) Authors: Corren, Jonathan; Pham, Tuyet‐Hang; Garcia Gil, Esther; Sałapa, Kinga; Ren, Pin; Parnes, Jane R.; Colice, Gene; Griffiths, Janet M. Journal: Allergy Issue: Volume 77:Issue 6(2022) Page Start: 1786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (18th May 2020) Authors: Agache, Ioana; Rocha, Claudio; Beltran, Jessica; Song, Yang; Posso, Margarita; Solà, Ivan; Alonso‐Coello, Pablo; Akdis, Cezmi; Akdis, Mubeccel; Canonica, Giorgio W.; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; Del Giacco, Stefano; Eiwegger, Thomas; Firinu, Davide; Gern, James E.; Hamelmann,... Journal: Allergy Issue: Volume 75:Issue 5(2020) Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma. Issue 5 (24th February 2020) Authors: Agache, Ioana; Beltran, Jessica; Akdis, Cezmi; Akdis, Mubeccel; Canelo‐Aybar, Carlos; Canonica, Giorgio Walter; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; Del Giacco, Stefano; Eiwegger, Thomas; Firinu, Davide; Gern, James E.; Hamelmann, Eckard; Hanania, Nicola; Mäkelä, Mika; Hernández‐Mart... Journal: Allergy Issue: Volume 75:Issue 5(2020) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Issue 5 (1st April 2020) Authors: Agache, Ioana; Song, Yang; Rocha, Claudio; Beltran, Jessica; Posso, Margarita; Steiner, Corinna; Alonso‐Coello, Pablo; Akdis, Cezmi; Akdis, Mubeccel; Canonica, Giorgio Walter; Casale, Thomas; Chivato, Tomas; Corren, Jonathan; del Giacco, Stefano; Eiwegger, Thomas; Firinu, Davide; Gern, James E.; ... Journal: Allergy Issue: Volume 75:Issue 5(2020) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗